Do Clopidogrel Nonresponders Have an Increased Risk of Adverse Events during Supra-Aortal Angioplasty and Stenting?
Open Access
- 28 February 2012
- journal article
- research article
- Published by Hindawi Limited in Stroke Research and Treatment
- Vol. 2012, 1-4
- https://doi.org/10.1155/2012/904534
Abstract
Objective. The aim of the present study was to correlate new periprocedural diffusion-weighted imaging (DWI) lesions during stenting of supra-aortal arteries with the level of platelet inhibition using point-of-care analysis.Background. Cardiological studies have shown that patients undergoing coronary PTA have a significantly elevated risk of severe thrombotic complications if patients show insufficient inhibition of platelet function.Methods. From August 2008 to June 2009, 44 patients with an indication of supra-aortal angioplasty and/or stenting were prospectively enrolled. Platelet reactivity was tested using a Multiplate device (Dynabyte). These patients underwent MRI before and after the intervention to determine the prevalence of new DWI lesions. The primary endpoint was the prevalence of DWI lesions; the secondary endpoint was clinical status until discharge from hospital.Results. There was no significant relationship between the primary endpoint and the degree of platelet function. Patients with high platelet reactivity showed the same amount of periprocedural complications as patients with sufficient inhibition of platelets.Conclusions. Clopidogrel did not have a protective effect on periprocedural complications, nor did it decrease the number of silent DWI lesions after the procedure. The predescribed strong relationship between high platelet reactivity and early post-procedural adverse events was not observed in our cohort.Keywords
This publication has 16 references indexed in Scilit:
- Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching TherapiesCirculation, 2010
- Role of Ticagrelor in Clopidogrel Nonresponders: Resistance Is Futile?Circulation, 2010
- Cytochrome P-450 Polymorphisms and Response to ClopidogrelNew England Journal of Medicine, 2009
- Point-of-Care Measurement of Clopidogrel Responsiveness Predicts Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention: Results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) StudyJournal of the American College of Cardiology, 2008
- Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantationEuropean Heart Journal, 2008
- Monitoring of Clopidogrel-Related Platelet Inhibition: Correlation of Nonresponse with Clinical Outcome in Supra-Aortic StentingAmerican Journal of Neuroradiology, 2008
- How to optimise clopidogrel therapy? Reducing the low-response incidence by aggregometry-guided therapy modificationThrombosis and Haemostasis, 2008
- Clinical implications of clopidogrel resistanceThrombosis and Haemostasis, 2008
- Incidence of New Brain Lesions After Carotid Stenting With and Without Cerebral ProtectionStroke, 2006
- Clopidogrel Effect on Platelet REactivity in Patients With Stent Thrombosis: Results of the CREST StudyJournal of the American College of Cardiology, 2005